An Australian influencer has given another heartbreaking update on her one-year-old daughter who was in a coma for 100 hours.

Infantile spasms, also known as West syndrome, is a rare but severe form of epilepsy that typically begins in the first year ...

Marc Goodman has given his Buy rating due to a combination of factors indicating a strong potential for Marinus’s ganaxolone in treating tuberous sclerosis complex (TSC). The company’s Phase 3 study ...

Marinus (MRNS – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Jay Olson from ...

Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today is hosting an Investor and Analyst Day ...

Sarcomas as rare cancers that develop in the bones and soft tissues, including fat, muscles, blood vessels, nerves, deep skin ...

There are different types of walking tests to assess for various symptoms. Multiple sclerosis (MS) is a condition that causes your immune system to attack the protective covering of your nerves.

Although multiple sclerosis (MS) and muscular dystrophy (MD) are both debilitating diseases that may seem similar, they are quite different in their cause, the way they affect the body, and how they ...

Epilepsy is very common in tuberous sclerosis complex and occurs in 80 to 90% of affected individuals during their lifetime. Onset usually occurs during childhood, and up to one third of children ...

Sept 12 (Reuters) - Stories on Roche receiving FDA approval for an injectable version of its multiple sclerosis therapy are incorrect and are withdrawn. There will be no replacement story.